Grant Lepley
Optometrist · Fond du Lac, WINPI 1831538727
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,141 of the $6,986 with a category attached, or 73.6%. Johnson & Johnson Vision Care, Inc. accounts for 60.8% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2022 at $2,859 and has fallen 82.7% since, to $494 in 2025. Among optometrist clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 200 payments — averaging $34.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$4K
- Bausch & Lomb Americas Inc.$538
- Bausch & Lomb, A Division Of Bausch Health US, LLC$410
- Coopervision Inc.$274
- Alcon$269
- Sun Pharmaceutical Industries Inc.$228
- plus $1K from 13 others
What the payments were for
- Consulting fees$1,84526%
- Food & beverage$5,14174%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 64 | $4,248 |
| Bausch & Lomb Americas Inc. | 26 | $538 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 24 | $410 |
| Coopervision Inc. | 18 | $274 |
| Alcon | 14 | $269 |
| Sun Pharmaceutical Industries Inc. | 7 | $228 |
| AbbVie(2 entities) | 12 | $227 |
| Dompe US, Inc. | 4 | $165 |
| Novartis | 8 | $156 |
| Amgen | 2 | $135 |
| Kala Pharmaceuticals, Inc. | 6 | $94 |
| Oyster Point Pharma, Inc. | 4 | $78 |
| Tarsus Pharmaceuticals, Inc. | 2 | $42 |
| Thea Pharma Inc. | 1 | $27 |
| Alcon Research LLC | 2 | $27 |
| Biotissue Holdings Inc. | 3 | $25 |
| Plexus Optix, Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $14 |
| Aerie Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acuvue$2,901
- INFUSE MULTIFOCAL$125
- Oxervate$125
- CEQUA$125
- TEPEZZA$120
How this compares
$6,986 in reported general payments places this provider in the 95th percentile of 867 optometrist providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorometholone | 34 | $2,525 |
| Latanoprost | 113 | $1,794 |
| Timolol Maleate | 52 | $587 |
| Prednisolone Acetate | 11 | $335 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 22 | $229 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 16 | $225 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Fond du Lac
- Jessica KulickFond du Lac$8K
- Cortney BirschbachFond du Lac$5K
- David NelsonMadison$256K
- Jennifer FrieheMukwonago$234K
- Tessa SokolMadison$105K
- Christopher LopezClintonville$48K
- Jeff BanasMount Pleasant$46K
- Jessica SchiffbauerKenosha$27K
- Jeffrey ClementsSun Prairie$16K
- Douglas HinsonSturtevant$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.